Why CSL shares are 'going to deliver' in 2022: fund manager

Quality growth companies can perform well even in an era of rising interest rates.

| More on:
Three scientists wearing white coats and blue gloves dance together in a lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

CSL Limited (ASX: CSL) shares, strong long-term performers, have faced unexpected tailwinds over the past few years, with the global pandemic impacting some of the company's operations.

While COVID disruptions appear to be easing for the S&P/ASX 200 Index (ASX: XJO) biotech company, shakeups in the market have seen the CSL share price drop 7.2% this year, while the ASX 200 itself has slipped 6.4%.

However, looking ahead, Jun Bei Liu, portfolio manager at Tribeca Investment Partners, says investment in CSL shares could help "future-proof your portfolio".

Fully funded and generating great cash flow

Speaking to Livewire, Liu said CSL shares top the list of ASX healthcare growth stocks she's been buying.

She said CSL shares have "been hit early in this calendar year on the basis that everyone else was buying resources, and BHP Group Ltd (ASX: BHP) became such a big part of the index".

Liu continued:

 Its earnings were hurt by the pandemic, simply because the blood collection was quite tough over the last few years. Now in its most recent update, CSL actually talked to that – it's actually picking up quite quickly, which means earnings will grow quite significantly after that short term disruption.

To me, that business is trading on a very reasonable multiple for the growth it is going to deliver. And very similarly, the company is fully funded, generating really great cash flow. It's really helping you to future-proof your portfolio.

Investors concerned about the impacts of rising interest rates and bond yields may also wish to investigate CSL shares.

According to Liu:

The bond yield, whether it's peaked now or whether it's in a month's time or whether it's further down the track, it doesn't really matter. This is a quality growth company. Soon the market will come back to those companies and realise that everywhere else growth is going to be hard to deliver.

CSL shares also pay a 1.1% trailing dividend yield, unfranked.

How have CSL shares performed longer-term?

As long-term investors, it can pay to take a step back and study long-term performance.

With that in mind, CSL shares have gained 109% over the past five years, handily outpacing the 24% gains posted by the ASX 200 over that same period.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

What to buy now with the ASX at a record high

Analysts think these shares could still rise strongly from current levels.

Read more »

A young man looks at a stylised investment graph superimposed on an exterior office building backdrop.
Growth Shares

Where to invest $10,000 in ASX 200 stocks today

Analysts think these high-quality shares are in the buy zone for investors right now.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Growth Shares

Two ASX industrials shares with buy recommendations

One broker believes these growth shares are set to rise.

Read more »

Man smiling at a laptop because of a rising share price.
Growth Shares

I think these 2 exciting ASX growth shares are buys today

These stocks could deliver big returns.

Read more »

a man in a business suit and carrying a laptop stands smiling with hand in pocket outside a large office building in a city environment.
Growth Shares

Buy these 2 impressive ASX 200 shares in July: experts

Experts are bullish about these two businesses.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

3 ASX 200 shares set to dominate the next decade

Let's see why these shares could be great long term picks for Aussie investors.

Read more »

A group of businesspeople clapping.
Growth Shares

3 ASX growth shares with 10-year compounding potential

Let's see which shares are being tipped as buys for growth investors.

Read more »

Woman happy and relaxed on a sofa at a shop.
Growth Shares

Are these 2 top ASX growth shares buys?

Are these high-flyers still buys?

Read more »